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Summary
Equine proliferative enteropathy (EPE) is a disease of foals caused by the obligate intracellular organism Lawsonia intracellularis. This emerging disease
affects mainly weanling foals and causes fever, lethargy, peripheral oedema, diarrhoea, colic and weight loss. The diagnosis of EPE may be challenging and
relies on thepresenceof hypoproteinaemia, thickeningof segments of the small intestinalwall observedupon abdominal ultrasonography, positive serology
and molecular detection of L. intracellularis in faeces. Although the clinical entity, diagnostic approach and treatment of EPE are well established and
described, the epidemiology for this disease has remained largely unaddressed. This article focuses on new developments in the field of EPE, including
epidemiology, pathophysiology, clinical signs, diagnosis, treatment and prevention.
The Summary is available in Chinese – see Supporting information.
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Introduction
Lawsonia intracellularis is the aetiological agent of the recently recognised
and emerging intestinal disease in horses called equine proliferative
enteropathy (EPE). Lawsonia intracellularis is an obligate intracellular,
motile, curved, Gram-negative bacterium that resides freely within the
apical cytoplasmof infected intestinal enterocytes [1]. The genus Lawsonia
was placed within the Desulfovibrionaceae family based on phylogenetic
analysis of 16S rDNA sequences and, to date, the Lawsonia genus contains
only one species [2]. Similar to theDesulfovibrionaceae, L. intracellularis is
anaerobic but differs from other members of the family in its inability to
reduce sulphate. In vivo, it causes proliferation of the affected enterocytes,
resulting in a thickened small and sometimes large intestine. Lawsonia
intracellularis can only be grown in vitro in cell culture and requires dividing
cells and a specific atmosphere for infection and growth [1]. Peak infection
occurs between 6 and 7 days of incubation. A single polar flagellum and
dartingmotility are observedwith extracellular L. intracellularis organisms
in cell culture. Besides horses, L. intracellularis infects many species of
domestic and wild animals, including pigs, hamsters, rabbits, foxes, deer,
ferrets, ostriches and nonhuman primates. The first published report of
proliferative enteropathy in horses was in 1982 by Duhamel andWheeldon
[3]. Since 1996, several reports of sporadic cases and outbreaks on
breeding farms have been described [4–21]. In the last few years, reported
casesofEPEhavebeen increasing,occurringprimarily inpostweaning foals
and occasionally in young adults [20]. The disease has almost reached a
worldwide occurrence and has been reported in the USA, Canada, Europe,
SouthAfrica, Australia, Brazil and Japan.
Pathogen characterisation
Molecular investigations of L. intracellularis isolates from proliferative
enteropathy lesions of a variety of animal species including horses and
hamsters, showed 98% homology of the 16S-rDNAgene to pig isolates [22].
Moreover, phenotypic characterisation of outer membrane proteins and
immunoblots of different L. intracellularis isolates using several antibodies
and more sensitive molecular characterisations of the L. intracellularis
genomedemonstratedonlyminor differences among isolates [23]. Noneof
these differences appear to be antigenically relevant. Recently, the whole
genome of a porcine L. intracellularis isolate was sequenced and analysed
for the presence of variable number tandem repeat (VNTR) sequences.
Variable number tandem repeat sequences in the genomes of prokaryotes
areoften associatedwith a high level of polymorphismandenable bacterial
strain differentiation with substantial discriminatory power. Use of these
L. intracellularis VNTR sequences provides a sensitive method for analysis
of the genetic relatedness of L. intracellularis bacteria or DNA obtained
from various temporal and geographical locations and from various animal
species. This provided insight into the phylogenetic relatedness of these
isolates. Molecular VNTR sequence profiles of L. intracellularis isolates
fromvarious documentedoutbreaks of proliferative enteropathy occurring
in pigs, horses, ostriches, spider monkeys, ferrets and rabbits were
analysed. Patterns emerged that provide some insight into the sources and
phylogenetic relatedness of L. intracellularis isolates from different
species. The VNTR sequence types obtained from pigs were very different
from those obtained from horses or other nonpig species. The VNTR
patternsdistributed the isolates into2distinct groups, thoseobtained from
pigs and those obtained from horses and other nonpig species. Little or no
genetic variationwas foundbetween isolates fromwithin outbreaks for any
animal species or in multiple temporal samples taken from the same
outbreak site. Slight variations between isolates obtained from outbreaks
at different geographic locations were found and though these differences
wereminor, theywere consistent and stable enough that outbreak isolates
could be identified and traced.
Epidemiology
In pig populations, the chronic form of the disease is maintained by
subclinically affected pigs or is established environmentally in some sites,
allowing transmission of L. intracellularis to serial flows of pigs [24]. Mice
and rats have been shown to be important reservoirs of L. intracellularison
pig farms with prevalences of PCR positive animals varying substantially
between farms (4–83%) [25,26]. Rodents appear to be suitable reservoir
hosts due to their susceptibility to L. intracellularis, their close contact
to domestic animals and high reproductive rate, which maintains
L. intracellularis across generations. The source of infection has not been
determined for horses. Exposure to pig faeces has been speculated as a
potential sourceof infection for horses since the first reported cases of EPE.
However, in most cases of EPE, no history or evidence of direct or indirect
exposure to pigs or pig faeces has been reported. Further, multi-locus
VNTR profiles of pig and equine isolates differ greatly. A recent
experimental study has shown host specificity for L. intracellularis isolates
cultured from pig or horse intestines [27]. The study showed that clinical
signs, longer periods of shedding and stronger serological immune
responseswereobserved in animals infectedwith species-specific isolates.
Previous studies have shown that a variety of wild and domestic animals
including dogs, cats, rabbits, opossums, skunks, mice and coyotes, can
shed L. intracellularis on farms with diagnosed EPE cases [28,29]. On a
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recently identified farm in northern California endemic for EPE, 7.5% of
faecal samples and 27% of serum samples from cottontail rabbits tested
PCR positive and seropositive for L. intracellularis, respectively [29]. Of
interest was that on this farm, a large population of cottontail rabbits lived
in the hay barn and had direct access to the hay fed to the horses. An
epidemiological investigation on this farm showed rabbit faeces on top of
hay bales but also in the feeders of the weanling foals, suggesting that the
foals developing EPE were likely exposed to L. intracellularis via the oral
ingestion of infected rabbit faeces (Figs 1, 2). Similar to rodents,
lagomorphsmay represent aneffective reservoir/amplifier host due to their
large population, their close contact to horses and short reproductive
cycle. It still remains to be determined how L. intracellularis became
endemic in the rabbit population on this farm.
Faeco–oral transmission of L. intracellularis has been documented in
naïve foals housed with clinically infected foals experimentally challenged
with an equine isolate of L. intracellularis [30]. A recent study has shown
that faeces from experimentally infected rabbits with an equine isolate of
L. intracellularis served as infectious material for weanling foals [31].
Although infected rabbits and foals remained asymptomatic, infection was
supported by faecal shedding of L. intracellularis and detection of specific
antibodies to L. intracellularis. Although the natural infectious dose
for foals has not been determined, pigs receiving as low as
105 L. intracellularis have been shown to develop infection [32]. Recent
work suggested that 1 g of infectious faeces would suffice to deliver the
above challenge dose [26]. It is the authors’ opinion that onmost farms, the
initial transmissionof L. intracellularisoccurs via theaccidental ingestionof
infectious faeces from one of the described or yet undetermined
amplifiers/hosts. Amplification of L. intracellularis and environmental
contamination leading to exposure rates of up to 100% of resident foals are
likely to occur secondary to the shedding of large quantities of
L. intracellularis from either clinically or subclinically infected foals.
In piglets, large group size, weaning, transportation, diet change and
mixing have been associated with clinical disease [1]. Predisposing
factors such as the stress of weaning, overcrowding, decline in
L. intracellularis-specific colostral antibodies, endoparasitism and
introduction of new animals have been suggested in the development of
EPE in foals [7]. In pigs, infection and faecal shedding of L. intracellularis
may persist for as long as 12 weeks [32]. This is in sharp contrast to
experimentally infected foals showing onset and duration of faecal
shedding ranging from 10 to 14 days and 17 to 27 days, respectively
[30,33]. Previouswork has shown that L. intracellularis is likely to survive in
environmental conditions for 1–2weeks at 5–15°C [34].
Pathogenesis and immune responses
The pathogenesis and pathophysiology of EPE has remained poorly
investigated and most of the information available has been extrapolated
from experimentally infected hamsters, pigs and rabbits. Comprehensive
studies of lesion development and evolution have been conducted in
pigs [35] and hamsters [36]. Morphological studies of early lesions in
experimentally infected animals indicate that enterocyte hyperplasia is
directly preceded by infection and replication of the intracellular organism
[35,36]. In vivo, the onset of hyperplasia associated with proliferative
enteropathy follows an increased number of intracellular L. intracellularis
in enterocytes. Likewise, resolution of the lesions is closely related to
disappearance of the intracellular organisms, indicating a correlation
between the 2 events [1]. The means by which L. intracellularis produces
hyperplasia or how the host cells respond to this infection are unknown.No
other cytopathological effects on infectedenterocytes are seen in vivoor in
vitro. Inflammation is a factor only in later stage lesions and is not
characteristic of theprimary lesion. Thepeakof lesiondevelopment in both
pigs and horses is about 21 days after infection but may vary according to
the dose of L. intracellularis.
While the dynamics of L. intracellularis infection have been well
characterised, little is known about the genetic basis for its virulence,
pathogenesisorphysiology.Bacterial isolatesat lowpassage induceclinical
andpathological changes typical of proliferativeenteropathybut isolatesat
highpassage incell cultureareattenuatedanddonot induce typical lesions.
Recently, the differential transcriptional profiles of a pathogenic (low
passage) and a nonpathogenic (high passage) isolate were determined in
order to define potential virulence factors [37]. The pathogenic isolate
showed a wider transcriptional landscape made up of plasmid-encoded
genes, regulatory factorsandATP-bindingcassette transportergenes. Loss
of pathogenicity in vivo of the high passage isolate appears to be due to
genesilencingmechanisms.Further, thisstudy identifiedanumberofgenes
expressed in pathogenic L. intracellularis that will make ideal targets for
development of further diagnostic and controlmeasures.
In horses, lesions are most commonly seen in the ileum, near the
ileal–caecal junction and appear as a thickening of the mucosa. Gross
lesions are not evident in all cases of EPE and may often be overlooked.
Intestines show an irregular, patchy subserosal oedema. The ileal mucosa
is thickened with deep folds and chronically affected animals may have
patches of pseudomembrane covering the mucosa (Fig 3). Hypertrophy
and thickening of themuscularis mucosamay occur in chronically affected
or recovering animals. Histologically, adenomatous proliferation occurs
among the epithelial cells in the crypts of the small intestine, in association
with the presence of curved, intracellular bacteria in the apical cytoplasm
of these enterocytes [3,4,7]. Severe proliferative enteropathy is diagnosed
by the demonstration of hyperplasia of the crypt glands with an increased
number of mitotic figures and marked reduction or absence of goblet cells
in routine haematoxylin and eosin preparations; however, for visualisation
of the bacteria in the cytoplasm of enterocytes, special stains are
Fig 1: Heavy contamination of hay with faeces from cottontail rabbits at a farm in
northern California with endemic occurrence of equine proliferative enteropathy.
Fig 2: Faeces from cottontail rabbits found at the bottom of a hay feeder in a weanling
pasture from a farm in northern California with endemic occurrence of EPE.
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necessary. The histological lesions of proliferative enteropathy are unique
and inflammation is not normally a hallmark of disease. Warthin-Starry
silver stain allows the detection of the bacteria in histological sections
(Fig 4), improving the diagnostic sensitivity, but the technique has
limitations when applied to autolysed and necrotic samples [1].
Immunohistochemistry procedures, using post mortem tissue or biopsy
material with an antibody specific for L. intracellularis, are considered the
gold standard for histological confirmation of EPE (Fig 5). Recently, Page
et al. [38] reported on fatal necrotising enteritis associated with
L. intracellularis in 4 foals. In these6- to 8-month-old foals, the clinical entity
was acute and followed by rapid clinical deterioration and death due to
endotoxaemia, bacteraemia or disseminated intravascular coagulation.
Cell-mediated immune response appears to be an important feature
in protecting animals from reinfection with L. intracellularis [39,40].
Descriptive immunocytological studies of intestinal tissue sections of pigs
affected by proliferative enteropathy, reveal amild infiltration of cytotoxic T
cells, macrophages and B lymphocytes carrying major histocompatibility
complex (MHC) class II structure at the beginning of the cell-mediated
immune response [41]. Immunohistochemical studies of intestinal sections
of naturally infected pigs also demonstrated a large accumulation of
immunoglobulin A (IgA) in the apical cytoplasmof proliferating enterocytes
[41]. Further, interferon gamma is produced by peripheral blood
mononuclear cells (PBMCs) of both pigs and horses following specific
stimulation [39,42,43] and L. intracellularis-specific IgA is detected in
intestinal lavages of challenged pigs [40]. Similarly, interferon gamma
played a role in limiting intracellular infection and increased cellular
proliferation in experimentally infectedmice [44].
Clinical and laboratory findings
There are characteristic case details, seasonality, clinical signs and blood
work abnormalities associated with EPE. The disease is generally
manifested in foals less than one year of age and in North America is often
seen between August and February [16]. Although the disease is
commonly seen in weanling foals 4–7 months of age, cases of EPE have
been seen in young adults [20]. Lethargy, anorexia, fever (>38.5°C),
peripheral oedema (ventrum, sheath, throatlatch and distal limbs; Fig 6),
weight loss (Fig 7), colic and diarrhoea are among the most common
clinical findings in affected foals. Early clinical signs are generally unspecific
and includemilddepression, partial anorexia and fever.Althoughdiarrhoea
is commonly seen in affected foals and can vary from cow pie to watery,
some affected foals may have normal faecal character. Foals with EPE may
also have concurrent disorders such as respiratory tract infections, gastric
Fig 3: Gross lesions of equine proliferative enteropathy of an 11-month-old
Thoroughbred colt with proliferative enteropathy showing a diffusely thickened
intestinal wall and patches of pseudomembrane covering themucosa.
Fig 4: Ileal mucosa from a 6-month-old Quarter Horse filly with proliferative
enteropathy. Aggregates of bacteria (arrows) are present in the cytoplasmof epithelial
cells of hyperplastic crypts (Warthin-Starry silver stain; bar = 30 mm).
Fig 5: Immunohistochemical stained section of small intestine from an 8-month-old
foalwithproliferativeenteropathy. Lawsonia intracellularis specific antibody stains the
bacteria lining the apical cytoplasm of the affected crypts (red areas).
Fig 6: Six-month-old Quarter Horse colt with proliferative enteropathy displaying
ventral and scrotal oedema.
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ulceration and intestinal parasitism. One must keep in mind that signs
of EPE may resemble those of more common gastrointestinal disorders
such as parasitism, bacterial infections (Clostridium spp., Salmonella
spp., Rhodococcus equi, Neorickettsia risticii), rotavirus, coronavirus,
ulcerations, sand accumulation, intestinal obstruction and intoxication
with plants, chemicals and pharmacologic agents such as nonsteroidal
anti-inflammatory drugs or antimicrobials. Similar to pigs, the disease can
be subclinical in foals and be manifested by a self-limiting and transient
decrease of total serum protein concentration coupled with decreased
daily weight gain when compared with unaffected foals [30,33]. It will
remain to be determined if growth retardation or unthriftiness are
associated with subclinical infection.
Themostconsistent laboratoryfindingofclinicalEPEishypoproteinaemia
due to hypoalbuminaemia. Total protein is generally less than 50 g/l and
albumin is usually less than 20 g/l. In a recent case report [16],
hypoalbuminaemiawastheonlyconsistentclinicopathologicalabnormality
of 57 affected foals with albumin concentrations ranging from 9 to 33 g/l
(normal reference range 27–42 g/l). The exact mechanisms by which
hypoalbuminaemia develops in affected foals has not been investigated. It
appears that a combination of decreased feed intake, coupled with
malabsorption and protein-losing enteropathy due to the proliferative
nature of the disease may represent likely mechanisms by which low
albumin occurs [45]. Experimentally infected hamsters had significantly
lower intestinal absorption of glucose, potassium and chloride, suggesting
thatmalabsorption is themainmechanism involved in the physiopathology
of thediarrhoea in L. intracellularis-infectedanimals [46].
Affected foals may also demonstrate nonspecific blood abnormalities
such as anaemia or haemoconcentration, leucocytosis or neutropenia,
hyperfibrinogenaemia, increased activity of muscle enzymes and
electrolyte abnormalities (hypocalcaemia, hypochloraemia and
hyponatraemia). Urine analysis to rule out protein-losing nephropathy
and cytological evaluation of abdominal fluid to rule out protein lost to a
third space are generally unremarkable.
Diagnosis
A presumptive diagnosis of EPE is generally made based on age of the
affected animal, clinical signs, hypoproteinaemia/hypoalbuminaemia,
presence of thickened small intestinal loops on ultrasonographic
evaluation and ruling out other causes of enteropathy and protein losses.
Abdominal ultrasonography, although not very sensitive, may show
segments of thickened small intestine (Fig 8) and excessive abdominal
fluid. In these cases, abdominocentesis will yield a noninflammatory
transudate. An ante mortem diagnosis is generally confirmed via PCR
detection of L. intracellularis in faeces or rectal swab and/or serology [47].
It is essential to combine both molecular and serological diagnostic
testing since these modalities have high analytical specificity but variable
sensitivity depending on the situation. Negative PCR results can be
expected if the faecal samples are collected from foals with prior
antimicrobial treatment or during advanced disease stage when
L. intracellularis organisms are no longer expected in the faeces. Negative
serological results can be expected in the early stage of the disease, when
humoral immune responses are not yet strong enough to be detectable by
serology. Further, differences in sensitivity among different PCR and
serological assays can lead todivergent results.AmongPCRassays, theuse
of real-time platform has been shown to yield the best sensitivity and to
reduce the likelihood of cross- or carry-over contamination (i.e. false
positive results) [48–50]. Several serological assays, including indirect
fluorescent antibody test (IFAT), enzyme-linked immunosorbent assay
(ELISA) and immunoperoxidase monolayer assay (IPMA), have all been
validated and established for pigs [51–54]. A preliminary comparative
study using equine serum samples has shown that various serology assays
are accurate; however, the IPMA is themost specific when determining the
presence of anti-L. intracellularis antibodies in adult horses with EPE (C.J.
Gebhart, personal communication).
Supportive and medical treatment
It is important to treat affected animals early before lesions become
advanced and result in marked weight loss and critically low serum protein
concentrations. Treatment of EPE in horses involves the use of
antimicrobials such as macrolides, alone or in combination with rifampin,
chloramphenicol, oxytetracycline or doxycycline administered for 2–3
weeks. The choice of antimicrobial in the treatment of EPE should take into
account the risk of inducing disturbance of the gastrointestinal flora and
renal toxicity. This is especially a concern when treating older foals with
severe hypoalbuminaemia. National and international policies on
antimicrobial use in horses should also be considered [55]. Supportive care
such as i.v. fluids, plasma transfusion, parenteral nutrients and anti-ulcer
drugs are commonly used to treat affected foals. Concurrent medical
conditions should also be addressed. Rapid clinical improvement following
treatment is to be expected; however, it may take weeks for the
hypoproteinaemia to resolve. Spontaneous recovery of clinically infected
foals has not been documented and up to 93% of treated foals usually
survive the disease [16]. However, in more recent years the authors have
seen more severe cases presented to veterinary hospitals with a poorer
outcome. Generally nonsurvivors develop complications associated with
Fig 7: Severe weight loss in a 5-month-old Quarter Horse colt with proliferative
enteropathy.
Fig 8: An ultrasound image showing a thickened section of small intestinal wall in a
7-month-old Thoroughbred colt with proliferative enteropathy. The wall thickness
measured between 5.4 and 6.0 mm (normal wall thickness3 mm).
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gastrointestinal translocation, gastrointestinal perforation or kidney failure
(38). At 2different veterinary hospitals, themortality rate in thepast 2 years
ranged from 13% (2/15) to 31% (4/13; N.M. Slovis and N. Pusterla, personal
communication). Recentwork by Frazer [16] showed that clinically affected
and successfully treated foals sold for an average of 68% of the average
price of unaffected foals by the same stallion [16]. However, theirmonetary
earnings from racingwere not significantly different fromother horses [56].
Monitoring and disease prevention
Based on clinical observations, it appears that the exposure rate to
L. intracellularis is higher than the clinical attack rate. That said, and
assuming that index cases are only the tip of the iceberg, it is always
advisable to test herdmates to determine their exposure and clinical
status. This is best achieved by collecting blood to determine the level of
anti-Lawsonia intracellularis antibodies by serology and to measure total
protein concentration by refractometry. Another more expensive
alternative is to measure total protein and/or albumin concentrations by
chemical analysis. The use of PCR testing of faeces fromhealthy herdmates
is not advised in this situation due to the expense of testing and low rate of
positivity. Also, the results frompreviousepidemiological studies show that
healthy herdmates rarely shed detectable L. intracellularis [47,57]. Daily
clinical monitoring of all herdmates is also recommended in order to
recognise early stages of disease. This is best achieved via daily physical
examination, including rectal temperature, and the regular assessment of
weight, allowing the calculation of daily weight gain. A positive titre by
IPMA (60) in a healthy herdmate with no hypoproteinaemia should be
viewed as past exposurewith no apparent disease or possibly early, not yet
clinically apparent, EPE. Seropositive or seronegative clinically healthy
herdmateswith hypoproteinaemia (<50 g/l) or hypoalbuminaemia (<30 g/l)
should undergo further diagnostic testing (cell blood count, abdominal
ultrasound examination, faecal PCR) to determine if L. intracellularis
infection is the cause of the hypoproteinaemia. Treating foals
with suspected EPE based only on clinical findings and
hypoproteinaemia/hypoalbuminaemia is not recommended, knowing the
risk associated with the use of antimicrobials. Healthy seronegative
herdmates with no hypoproteinaemia should continue to be monitored
daily for clinical signs and bimonthly for hypoproteinaemia and/or
hypoalbuminaemia and detectable antibodies to L. intracellularis. Any foal
developing clinical signs of EPE should undergo a thorough diagnostic
assessment. Further, clinically affected foals or foalswith suspected clinical
EPE should be separated from the rest of the healthy herdmates in order to
decrease environmental contamination until their shedding status has
beendeterminedbyPCR. It has beenpreviously shown that experimentally
infected foals start shedding L. intracellularis5–17daysprior todeveloping
hypoproteinaemia and clinical signs [30]. It is this prodromal stage of
subclinically infected foals that is likely responsible for the environmental
contamination (including potential carriers, vectors and multipliers) and
exposure of susceptible foals.
The monitoring of a herd with endemic status follows guidelines similar
to those for herds with diagnosed index cases. This includes the regular
physical evaluation of resident foals and bimonthly assessment of total
protein concentration and serological status. Monitoring for exposure to
L. intracellularis and hypoproteinaemia/hypoalbuminaemia should begin
at least 4 weeks prior to the historical first detection of clinical cases.
Bimonthly data, including concentration of total serum solids or albumin
and weight gains, should be evaluated for each foal and compared with
the previous data in order to determine decreasing trends potentially
associated with early disease. Recent work performed in central Kentucky
has shown a seasonality to EPE cases with peak cases recorded in
November and December [16]. Year to year variations depending on
climatic conditions can be expected; however, most of the EPE cases are
seen between August and February in the northern hemisphere, as
recently weaned foals are primarily affected. Considering the cost of
treating a foal with clinical EPE, this monitoring programme is cost
effective, especially if measurement of total serum solids concentrations
can be performed by farm personnel. The lack of epidemiological data
regarding potential natural reservoir hosts as well as the paucity of
information pertaining to the biology of L. intracellularis precludes the
institution of any management changes on endemic farms. Early
recognition of clinical cases and separating them from the rest of the
susceptible foals until full recovery or cessation of faecal shedding
appears to be a logical biosecurity measure to prevent spread and
environmental contamination. Further, maintaining good pest control and
preventing nonequine domestic and wild animals from gaining access to
feed and feeding areas may potentially minimise the risk of disease
spread.
Prevention strategies have been best described in pigs using in-feed
antimicrobials and a commercially available L. intracellularis vaccine
[39,58,59]. Recent work has shown that detectable humoral and cellular
responses can be measured in foals administered an avirulent live
L. intracellularis vaccine [33,60–62]. The recently established vaccine
protocol has shown that the intrarectal administrationof 30 ml of either the
lyophilised or the frozen-thawed formulation of the avirulent
L. intracellularis vaccine given twice, 30 days apart, yielded the strongest
immunological responses [60]. The L. intracellularis vaccine has been
shown tobe safe andadministrationwell toleratedby the foals. Further, the
avirulent L. intracellularis vaccine has not been associated with the
induction of clinical disease in pigs or foals. Faecal shedding for up to 12
days has been documented following intrarectal vaccine administration in
foals [60]. Using the abovementioned protocols, vaccine efficacy has been
evaluated in the field and, more recently, under experimental conditions. A
field efficacy trial performed on EPE endemic farms in central Kentucky
in 2008 showed that vaccinated foals maintained higher daily weight
gains and higher total protein concentrations when compared with a
nonvaccinated, naturally seroconverted group [63]. Due to the low
incidence of disease reported on the study farms, no difference in attack
rate between vaccinated and nonvaccinated foals could be determined.
Theoverall decreaseddiseaseprevalence in the studypopulationmayhave
been associated with the ongoing vaccine trial on these farms, as disease
prevalence in central Kentucky did not change in 2009 compared with
2008. Potential explanations for the decreased number of clinical cases
were the elimination of so called ‘super shedders’ and possible exposure of
nonvaccinated foals to L. intracellularis vaccine organism shed in the
faeces of recently vaccinated foals. Under experimental conditions,
weanling foals vaccinated intrarectallywith an avirulent live vaccine against
L. intracellularis were protected against clinical and subclinical EPE
following challenge exposure with a virulent L. intracellularis isolate of
equine origin [33]. This was determined by lack of clinical disease, absence
of hypoproteinaemia and ultrasonographic abnormalities compatible with
EPE and a significant reduction in L. intracellularis faecal shedding in
vaccinated foals compared with nonvaccinated foals. Further, average
daily weight gains from the vaccinated foals over the entire study period
were similar to the control foals and significantly higher when compared
with the nonvaccinated foals, highlighting the benefit of the vaccine in the
prevention of subclinical disease. The extra-label use of the
L. intracellularis vaccine should be considered on naïve and endemic
farms in an attempt to reduce or prevent EPE. Timing of vaccine
administration should again be synchronised with historical disease
occurrence. Further, routine monitoring for clinical signs and
hypoproteinaemia/hypoalbuminaemia is still recommended even when
vaccine prophylaxis is used.
Conclusions
Equine proliferative enteropathy is an emerging disease with an
increasing number of cases reported each year. It also appears that the
disease is becoming endemic on an increasing number of horse farms.
Equine proliferative enteropathy commonly affects foals less than 12
months of age and is clinically characterised by lethargy, anorexia, fever,
peripheral oedema, weight loss, colic and diarrhoea. A presumptive
diagnosis of EPE is generally made based on age of the affected animal,
clinical signs, hypoproteinaemia/hypoalbuminaemia and presence of
thickened small intestinal loops on ultrasonographic evaluation. An
ante mortem diagnosis is generally confirmed via PCR detection of
L. intracellularis in faeces or rectal swab and/or serology. Treatment of
affected animals consists of supportive and medical treatment including
antimicrobials, i.v. fluids, plasma transfusion, parenteral nutrients and
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anti-ulcer drugs. Concurrent medical conditions should also be
addressed. Treatment of affected foals generally results in clinical
improvement, especially if treatment is initiated early in the course of the
disease.
Theprogressivenatureof EPEmakes this diseaseaprimecandidate tobe
monitored for in endemic herds. Monitoring strategies combine daily
physical evaluation combined with regular measurement of serum
protein/albumin concentration and antibodies against L. intracellularis.
Until new information regarding the epidemiology of this disease is
available, preventive strategies are restricted to the use of an avirulent
L. intracellularis vaccine. The use of the L. intracellularis vaccine should be
considered on naïve and endemic farms in an attempt to reduce or prevent
EPE.
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